# Bodi Envi Pricing Reference

Canonical plans page: https://bodienvi.com/pricing

## Important Pricing Information

Current published pricing is shown below. Pricing, availability, and program eligibility may change. Review the applicable treatment or Plans page before enrolling.

Medication is included only when a licensed healthcare provider determines treatment is medically appropriate and issues a prescription. Completing an assessment does not guarantee a prescription.

## Semaglutide Weight-Management Programs

| Plan | Monthly Equivalent | Billing |
|---|---|---|
| 12 months | $125 per month | $1,500 paid once |
| 6 months | $135 per month | $810 paid once |
| 3 months | $145 per month | $435 paid once |
| Monthly | $155 per month | Billed monthly |

## Tirzepatide Weight-Management Programs

| Plan | Monthly Equivalent | Billing |
|---|---|---|
| 12 months | $175 per month | $2,100 paid once |
| 6 months | $205 per month | $1,230 paid once |
| 3 months | $219 per month | $657 paid once |
| Monthly | $229 per month | Billed monthly |

## Brand Name Medications
FDA-approved brand name products in sealed manufacturer packaging, prescribed by a licensed provider after the online assessment and filled by partner pharmacies. Pricing starts at the figure shown and varies by the dose prescribed; the exact price is shown before payment. Zepbound® and Wegovy® are FDA approved for chronic weight management; Mounjaro® and Ozempic® are FDA approved for type 2 diabetes and are prescribed for weight management off label when a provider decides it is appropriate.

| Product | Starting at | Page |
|---|---|---|
| Zepbound® | $1,399 per month | https://bodienvi.com/zepbound |
| Mounjaro® | $1,399 per month | https://bodienvi.com/mounjaro |
| Wegovy® | $1,699 per month | https://bodienvi.com/wegovy |
| Ozempic® | $1,399 per month | https://bodienvi.com/ozempic |

## Compounded-Medication Notice

Compounded personalized semaglutide and compounded personalized tirzepatide are not FDA-approved and are not equivalent to FDA-approved products.

The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed.

Applicable state boards of pharmacy regulate and inspect 503A compounding pharmacies. Pharmacy operations and sterile compounding practices are subject to applicable U.S. Pharmacopeia standards.

Treatment is not guaranteed. A licensed healthcare provider determines whether treatment is appropriate for each individual patient. Individual experiences and outcomes vary.

Brand name medications referenced on this site, including Zepbound®, Mounjaro®, Wegovy® and Ozempic®, are registered trademarks of their respective owners. Bodi Envi is not affiliated with, endorsed by, or sponsored by those trademark holders. Brand name products are prescribed by licensed providers when clinically appropriate and are filled by partner pharmacies; brand names are otherwise used to explain that compounded medications are not equivalent to FDA-approved branded products.

## Contact Information

- Website: https://bodienvi.com/
- Phone: 1-855-348-2630
- Email: info@bodienvi.com
- Address: 6904 W Linebaugh Ave, Tampa, FL 33625, United States